explore -WSS

explore

author：Wikipedia 2025-09-29 22:38:23 - browse：3621

Beth Israel Deaconess Medical Center in Boston — David L. Ryan/The Boston Globe

Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry.

While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.

Industry leaders are calling for urgent action from the Healey administration and the Legislature to help stem the crisis. Even just simplifying the state regulatory bureaucracy and approvals for bringing uninsured patients into the MassHealth system would help, executives say.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： PBM reforms clear House panel

knowledge

WSS

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Wegovy, Zepbound and weight loss drugs that preserve muscle

STAT Summit: The economic case for universal basic health care

Results on Novartis prostate cancer therapy could expand its use

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

focus

explore

entertainment

Continuity nursing helped my family in our darkest PICU moments

Readout LOUD podcast: Live from the 2023 STAT Summit

After affirmative action ruling, medical educators look to 'holistic review'

A daunting task: navigating dual Medicare, Medicaid eligibility

Malaria cases in Florida and Texas: Here’s what you need to know

Astellas still sees hope in its gene therapy after four deaths

Peter Hotez and the public health issue of online harassment

Roche drug slashes death risk in early

Novavax promises a turnaround & Lilly roils the obesity market

Does good food count as health care? Study aims to find out

explore

STAT Readout Newsletter: Biotech news today

In key trial, Verve's treatment lowers cholesterol levels in patients

Smaller biotechs seek to piggyback on weight loss drug boom

In key trial, Verve's treatment lowers cholesterol levels in patients

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Gain of function research would be limited under House proposal

Wikipedia

knowledge

focus

hotspot